Buck Institute

The patent is based on the work of Aelan's founder and covers an epigenetic  biomarker associated with DNA damage, cellular senescence, and aging.

A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

A recent protein interaction study revealed that invertebrates have more in common with humans when it comes to the aging process than had been previously known, and that "the broad patterns underlying genetic control of life span in invertebrates is highly relevant to human aging and longevity."

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.